iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 34.0% in April

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a significant drop in short interest in April. As of April 30th, there was short interest totaling 1,522 shares, a drop of 34.0% from the April 15th total of 2,307 shares. Based on an average daily volume of 1,233 shares, the days-to-cover ratio is currently 1.2 days. Approximately 1.0% of the company’s stock are short sold.

iShares Neuroscience and Healthcare ETF Stock Down 0.6%

IBRN stock opened at $33.75 on Wednesday. iShares Neuroscience and Healthcare ETF has a twelve month low of $21.78 and a twelve month high of $37.00. The stock’s 50 day moving average is $33.56 and its 200-day moving average is $32.27. The firm has a market capitalization of $5.06 million, a PE ratio of 15.61 and a beta of 0.77.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.